Cargando…

Impact of oral antidiabetic agents on bone metabolism

Detalles Bibliográficos
Autores principales:	Paul, Thomas V., Thomas, Nihal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510717/ https://www.ncbi.nlm.nih.gov/pubmed/26112838 http://dx.doi.org/10.4103/0971-5916.159244

Ejemplares similares

Using AHRQ’s Evidence-Based Reports to Improve Managed Care Pharmacy Practice: Oral Antidiabetic Agents
por: Yeung, Kai
Publicado: (2011)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013)

Athero-protective actions of two oral antidiabetic drugs: Suppression of inflammation and oxidative stress
por: Chen, Kan
Publicado: (2012)

New Antidiabetes Agent Targeting Both Mitochondrial Uncoupling and Pyruvate Catabolism: Two Birds With One Stone
por: Rui, Liangyou
Publicado: (2019)

The Effect of Oral Antidiabetic Agents on A1C Levels: A systematic review and meta-analysis
por: Sherifali, Diana, et al.
Publicado: (2010)

Yoga- a potential solution for diabetes & metabolic syndrome
por: Naik, Dukhabandhu, et al.
Publicado: (2015)

Gliptins: A New Class of Oral Antidiabetic Agents
por: Seshadri, K. G., et al.
Publicado: (2009)

Detection and Delineation of Oral Cancer With a PARP1-Targeted Optical Imaging Agent
por: Kossatz, Susanne, et al.
Publicado: (2017)

Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis
por: Gamble, JM, et al.
Publicado: (2008)

Odontonutraceuticals: Pleiotropic Phytotherapeutic Agents for Oral Health
por: Varoni, Elena Maria, et al.
Publicado: (2016)

Selective Insulin Receptor Modulators (SIRM): A New Class of Antidiabetes Drugs?
por: Vigneri, Riccardo, et al.
Publicado: (2012)

Sodium–glucose cotransporter 2 inhibitors: A drug with antidiabetic and cardioprotective properties
por: Li, Hung‐Yuan
Publicado: (2020)

A comparative evaluation of medicine package inserts for oral antidiabetic agents in Palestine
por: Eshtayeh, Malak, et al.
Publicado: (2019)

Conventional antidiabetic agents and bone health: A pilot case–control study
por: Raj, Jeffrey Pradeep, et al.
Publicado: (2019)

Apolipoprotein M and Sphingosine-1-Phosphate: A Potentially Antidiabetic Tandem Carried by HDL
por: Yalcinkaya, Mustafa, et al.
Publicado: (2020)

Honey - A Novel Antidiabetic Agent
por: Erejuwa, Omotayo O., et al.
Publicado: (2012)

The effects of antidiabetic agents on heart failure
por: Wijnen, M., et al.
Publicado: (2021)

Anacardium occidentale Bark as an Antidiabetic Agent
por: Encarnação, Sofia, et al.
Publicado: (2022)

Genetics of obesity in consanguineous populations – A road map to provide novel insights in the molecular basis and management of obesity
por: Kapoor, Nitin, et al.
Publicado: (2019)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
por: Lu, Qingguo, et al.
Publicado: (2019)

How should one tackle prediabetes in India?
por: Jose, Jacob, et al.
Publicado: (2018)

Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
por: Philis-Tsimikas, A, et al.
Publicado: (2013)

Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
por: Hermansen, Kjeld, et al.
Publicado: (2008)

The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
por: Wu, Chen-Ning, et al.
Publicado: (2020)

Exenatide: A New Promising Antidiabetic Agent
por: Chakraborti, C. K.
Publicado: (2010)

Role of red grape polyphenols as antidiabetic agents
por: Pandey, Kanti Bhooshan, et al.
Publicado: (2014)

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
por: Ahn, Chang Ho, et al.
Publicado: (2019)

In the Search of Glycoside-Based Molecules as Antidiabetic Agents
por: Pałasz, Aleksandra, et al.
Publicado: (2019)

The Anti-Inflammatory Effect of Novel Antidiabetic Agents
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

SGLT inhibitors as antidiabetic agents: a comprehensive review
por: Kshirsagar, Rahul P., et al.
Publicado: (2020)

Mechanochemical Synthesis of Thiazolidinone-Triazoles Derivatives as Antidiabetic Agents: Pharmacokinetics, Molecular Docking, and In Vitro Antidiabetic Properties
por: Taj, M. B., et al.
Publicado: (2023)

The Antidiabetic Agent Metformin Inhibits IL-23 Production in Murine Bone-Marrow-Derived Dendritic Cells
por: Matsuda-Taniguchi, Tomoyo, et al.
Publicado: (2021)

Research Recommendations for Selected IARC-Classified Agents: Impact and Lessons Learned
por: Turner, Michelle C., et al.
Publicado: (2023)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Pharmacological evaluation of embelin - chitosan nanoparticles as an antidiabetic agent
por: Maanvizhi, Saba, et al.
Publicado: (2022)

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
por: Gundogdu, Evren, et al.
Publicado: (2014)

The prescribing trend of oral antidiabetic agents for type 2 diabetes in Taiwan: An 8-year population-based study
por: Chu, Wei-Min, et al.
Publicado: (2017)

Impact of ER Protein Homeostasis on Metabolism
por: Yalcin, Abdullah, et al.
Publicado: (2013)

Design, Synthesis and Pharmacological Evaluation of Novel Vanadium-Containing Complexes as Antidiabetic Agents
por: Fedorova, Elena V., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bohdv40ojkqtq9342ef0c1lbj3